Amy Quillo is an Oncology physician affiliated with University of Louisville. OpenAlex indexes 36 publications with 617 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
401 E Chestnut St
Suite 710
Louisville, KY 402025700
Telephone
502-583-8303Registry record last updated 26 Oct 2016.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- Insulet CorporationProgram year20242 payments
- Novo Nordisk IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
48.6%Opioid Agonist48.6%Hydrocodone-Acetaminophen100%Part D≥72 patientsHormonal (systemic)
33.8%l-Thyroxine33.8%Levothyroxine Sodium100%Part D≥24 patientsMetabolism & gastrointestinal
17.6%Vitamin D3 Analog17.6%Calcitriol100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Final Analysis of a Phase 2 Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer
International Journal of Radiation Oncology*Biology*Physics
2021 - Five-Year Report of the Institutional Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer
International Journal of Radiation Oncology*Biology*Physics
2021 - Patient Reported Outcomes and Cosmesis Following Once Weekly Hypofractionated Breast Irradiation
International Journal of Radiation Oncology*Biology*Physics
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Kelly McMasters, MD
University of Louisville
Stephen McClave, MD
University of Louisville
Robert Friedland, MD
University of Louisville
Charles Scoggins, MD
University of Louisville
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”